Literature DB >> 8800924

Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study.

E Nelis1, C Van Broeckhoven, P De Jonghe, A Löfgren, A Vandenberghe, P Latour, E Le Guern, A Brice, M L Mostacciuolo, F Schiavon, F Palau, S Bort, M Upadhyaya, M Rocchi, N Archidiacono, P Mandich, E Bellone, K Silander, M L Savontaus, R Navon, H Goldberg-Stern, X Estivill, V Volpini, W Friedl, A Gal.   

Abstract

A European collaboration on Charcot-Marie-Tooth type 1 (CMT1) disease and hereditary neuropathy with liability to pressure palsies (HNPP) was established to estimate the duplication and deletion frequency, respectively, on chromosome 17p11.2 and to make an inventory of mutations in the myelin genes, peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ) and connexin 32 (Cx32) located on chromosomes 17p11.2, 1q21-q23 and Xq13.1, respectively. In 70.7% of 819 unrelated CMT1 patients, the 17p11.2 duplication was present. In 84.0% of 156 unrelated HNPP patients, the 17p11.2 deletion was present. In the nonduplicated CMT1 patients, several different mutations were identified in the myelin genes PMP22, MPZ and Cx32.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800924     DOI: 10.1159/000472166

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  74 in total

Review 1.  Genetic neuromuscular disease.

Authors:  Mary M Reilly; Michael G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

Review 2.  Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies.

Authors:  Kinga Szigeti; Eva Nelis; James R Lupski
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Charcot-Marie-Tooth disease subtypes and genetic testing strategies.

Authors:  Anita S D Saporta; Stephanie L Sottile; Lindsey J Miller; Shawna M E Feely; Carly E Siskind; Michael E Shy
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

4.  [Delayed paresis of the femoral nerve after total hip arthroplasty associated with hereditary neuropathy with liability to pressure palsies (HNPP)].

Authors:  A Schuh; V Dürr; H Weier; G Zeiler; M Winterholler
Journal:  Orthopade       Date:  2004-07       Impact factor: 1.087

5.  Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome.

Authors:  Pawandeep Dhami; Alison J Coffey; Stephen Abbs; Joris R Vermeesch; Jan P Dumanski; Karen J Woodward; Robert M Andrews; Cordelia Langford; David Vetrie
Journal:  Am J Hum Genet       Date:  2005-03-08       Impact factor: 11.025

6.  Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice.

Authors:  Agnes Patzkó; Yunhong Bai; Mario A Saporta; István Katona; Xingyao Wu; Domenica Vizzuso; M Laura Feltri; Suola Wang; Lisa M Dillon; John Kamholz; Daniel Kirschner; Fazlul H Sarkar; Lawrence Wrabetz; Michael E Shy
Journal:  Brain       Date:  2012-12       Impact factor: 13.501

7.  Evidence of a founder haplotype refines the X-linked Charcot-Marie-Tooth (CMTX3) locus to a 2.5 Mb region.

Authors:  Megan Brewer; Febriani Changi; Anthony Antonellis; Kurt Fischbeck; Patsie Polly; Garth Nicholson; Marina Kennerson
Journal:  Neurogenetics       Date:  2008-05-06       Impact factor: 2.660

8.  Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial.

Authors:  Camiel Verhamme; Rob J de Haan; Marinus Vermeulen; Frank Baas; Marianne de Visser; Ivo N van Schaik
Journal:  BMC Med       Date:  2009-11-12       Impact factor: 8.775

Review 9.  Implications of germline copy-number variations in psychiatric disorders: review of large-scale genetic studies.

Authors:  Masahiro Nakatochi; Itaru Kushima; Norio Ozaki
Journal:  J Hum Genet       Date:  2020-09-21       Impact factor: 3.172

10.  PMP22 expression in dermal nerve myelin from patients with CMT1A.

Authors:  Istvan Katona; Xingyao Wu; Shawna M E Feely; Stephanie Sottile; Carly E Siskind; Lindsey J Miller; Michael E Shy; Jun Li
Journal:  Brain       Date:  2009-05-15       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.